Acquisition of Nicox’s US ophthalmic diagnostics subsidiary by Valeant
Valeant Pharmaceuticals International, Inc. has acquired Nicox’s US diagnostics subsidiary Nicox Inc., in a deal worth up to $20 million. Nicox intends to concentrate its commercial and development resources on ophthalmic therapeutics.
777 Main Street, Suite 2160
Fort Worth, Texas 76102
Tel: +1 817 529 9300
Fax: +1 817 612 6766
MyNicox concierge service
Any question or comment? Feel free to contact MyNicox concierge service.
PO Box 220425
Chantilly, VA 20153
1.855.MY.NICOX (696.4269) Email
Are you a healthcare professional?
To access this section of our website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.